chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left leg is numb and has tingling sensation, left eye droopy. Healthcare professional ruled out stroke.
Lethargic, swelling to elbow on injected arm, fever for 2 days, bright red area, nausea.
I started to feel like the in the morning that I felt weird and like my whole world was off. I took my blood pressure, and it was high. I talked to my doctor and they advised that I should go to the ER and I went to the ER and they diagnosed me with vertigo. My balance was completely off. He did give me medicine for the dizziness. He advised to have a follow-up.
This spontaneous report as received from nurse via company representative refers to a patient of unknown age and gender. Patient's medical history and other drug allergic reactions were not reported. On unspecified dates in 2008, a patient received 2 doses of GARDASIL (strength, dose unit, route, lot# and expiry date unknown). Then, on an unspecified date in 2014, that patient received the 3rd dose of GARDASIL (strength, dose unit, route, lot# and expiry date unknown). No known adverse effects were reported. The outcome of in 2008, patient received 2 doses of GARDASIL, in 2014 received the 3rd dose of GARDASIL and no adverse effect was unknown. No further information provided. Additional information has been requested.
Right side of face was very swollen; This spontaneous case was reported by a patient family member or friend and describes the occurrence of SWELLING FACE (Right side of face was very swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.   No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 14-Apr-2021, the patient experienced SWELLING FACE (Right side of face was very swollen) (seriousness criterion medically significant). At the time of the report, SWELLING FACE (Right side of face was very swollen) outcome was unknown.  The reporter was the husband of the patient.  The action taken with mRNA-1273 in response to the event was not applicable.  Concomitant medications were not reported. No treatment information was provided.  It was reported that after administration of the second dose of the vaccine (product not specified) on an unspecified date, the patient developed swelling of the right side of her face on 14-Apr-2021.   It was reported that she was sent to the ER (emergency room) by her PCP (primary care physician), where she was given intravenous steroids.  Company Comment: This case concerns a female of unknown age with a serious unexpected event of swelling face. Event latency within 24 hours after second dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns a female of unknown age with a serious unexpected event of swelling face. Event latency within 24 hours after second dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Leg pain in 10/20/09.  Lab ordered and showed rhabdomyolysis.
Case number PHEH2014US019842, is an initial spontaneous report received from a health care professional on 30 Sep 2014.  This report refers to a 64 year old female patient. She was vaccinated with FLUVIRIN (batch number: 1410701) intramuscular on 29 Sep 2014. On the same she developed swelling at injection site and entire arm hurts. Outcome of the event, seriousness and causality assessment was not reported.
Wednesday 5/5/2021  I had the worst headache and ear ache , I have ever experienced up to that point.  I was able to make an appointment  for late that afternoon with my primary care doctor. He examined me, didnt think i had a sinus or ear infection, he did put me on an antibiotic and told me to get to my ENT as soon as possible.   I saw my ENT Dr on Friday 5/7/2021.  it was he who identified my Sudden Idiopathic Sensorineural Hearing Loss ( right side). He was able to rapidly diagnose this by using an in office test followed by a hearing test.
Around 5/4/22 had a 2 day period of extreme fatigue. No fever but developed an ache in my left chest area. Felt like I was experiencing heart murmurs.
Injection site became red and itchy, area of erythema 4cmX4cm. Provided with hydrocortisone, skin pen used to mark area for pt to monitor for increasing size. Pt instructed to return on 10/13/15 for further eval.
Pt called office and an apt was made to see Dermatologist. Pt. c/o scattered , red plaques on his trunk , upper and lower extremities 3 mornings after his shot. Pt denied any itching
This case was reported by a other health professional via patient support programs and described the occurrence of influenza-like symptoms in a 61-year-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2018-2019 season) for prophylaxis. Co-suspect products included epoprostenol sodium (Flolan) powder for infusion for pulmonary arterial hypertension and glycine, sodium chloride, mannitol (Flolan Diluent Ph 12) solution for injection for pulmonary arterial hypertension. On 15th November 2018, the patient received Influenza vaccine Quadrivalent 2018-2019 season. On 6th October 2017, the patient started Flolan 1.5 mg at an unknown frequency and Flolan Diluent Ph 12 at an unknown dose and frequency. On 15th November 2018, less than a day after receiving Influenza vaccine Quadrivalent 2018-2019 season and 1 year and 40 days after starting Flolan and Flolan Diluent Ph 12, the patient experienced influenza-like symptoms. The action taken with Flolan was unknown (Dechallenge was unknown). Rechallenge with Flolan was unknown. The action taken with Flolan Diluent Ph 12 was unknown (Dechallenge was unknown). Rechallenge with Flolan Diluent Ph 12 was unknown. On an unknown date, the outcome of the influenza-like symptoms was unknown. It was unknown if the reporter considered the influenza-like symptoms to be related to Influenza vaccine Quadrivalent 2018-2019 season, Flolan and Flolan Diluent Ph 12. Additional details were provided as follows: The day before reporting, the patient received flu vaccine and experienced flu like symptoms on the same day. No other information was reported. This case had been linked with the cases A1013859A, US2017GSK073365, US2017GSK133031, US2017GSK137081, US2017GSK148310, US2017GSK184381 and US2018GSK196642, reported for the same patient.
Received H1N1 mist @ school clinic, developed fever, H/A and cough 48 hours after vaccine administered. 48 hours later fever, H/A resolved. Continued to have cough and developed runny nose. 2/17/10 when mom presented at MDs office still c/o runny nose/cough.
I had severe headaches and severe fatigue for about three to four days. I had a migraine for three days in a row and I had to take rizatriptan. I had upper respiratory congestion and I took MUCINEX for that. That lasted about 6-7 days. I took a round of PAXLOVID for 5 days. Currently, I feel fine.
We usually only carry Varicella and MMR Vaccines for kids. Did not realize that you could order MMR & Varicella in one shot. However the last time MMR was ordered we ordered the combo dose not even realizing. Went to give child their MMR and Varicella and the child actually received the Varicella and the MMR/Varicella combo. Had immunization Monitoring review and realized that this was what happened. Add new immunizations storage bin with correct labeling for the new MMR/Varicella that is not in stock
Pt recvd vax SEP90 & recvd 2nd dose in FEB92 approx 1mo p/2nd dose exp fatigue, muscle aches, paresthesia of rt hand & rt leg, numbness in facial area & some blurred vision; PE nl & blood chem nl; some arthralgia;
Patient received  dose of vaccine that may be less than completely effective due to storage conditions.  No adverse effects noted.
fever, confusion, R/O TIA, fever, chills, generalized weakness, blood sugar 400 and above
Person who first dose of Moderna vaccine...was a 17 year old; A spontaneous report was received from a pharmacist concerning a 17-year-old consumer who received Moderna's COVID-19 vaccine and was at an inappropriate age at vaccine administration.                           The patient's medical history was not provided. No relevant concomitant medications were reported.  On 01 Jan 2021 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection.     On 01 JAN 2021, a 17-year-old patient was given the vaccine and is outside the lower age limit for Moderna's mRNA-1273 vaccine. No adverse events were reported.  No treatment information was provided.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.    The event, inappropriate age at vaccine administration, was considered resolved on 01 Jan 2021.; Reporter's Comments: This case concerns a 17 year old patient.  The patient's medical history is not provided.  The event occurred on 01 Jan 2021 during administration of the first dose of the mRNA-1273. This report refers to a case of medication error where mRNA-1273  has been administered to the patient of inappropriate age.  There were no reported adverse  reaction associated with this case.
Information has been received from a registered pharmacist concerning a female who on approximately 05-NOV-2008 was vaccinated with ZOSTAVAX (LOT # was not reported). On approximately 05-NOV-2008 the patient experienced rash around the injection site after receiving ZOSTAVAX but it was no itchy or warm. She also experienced lower jay pain. The patient's rash around the injection site and lower jaw pain persisted. It was reported the patient sought unspecified medical attention. Additional information has been requested.
hot to touch; arm Itchy; arm  red; swollen down to her elbow; arm hurt for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (arm Itchy), VACCINATION SITE PAIN (arm hurt for 2 days), VACCINATION SITE ERYTHEMA (arm  red) and VACCINATION SITE SWELLING (swollen down to her elbow) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm hurt for 2 days). On 02-Feb-2021, the patient experienced VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE PRURITUS (arm Itchy), VACCINATION SITE ERYTHEMA (arm  red) and VACCINATION SITE SWELLING (swollen down to her elbow). The patient was treated with HYDROCORTISONE (CORTISONE [HYDROCORTISONE]) for Itching, at a dose of 1 dosage form. On 30-Jan-2021, VACCINATION SITE PAIN (arm hurt for 2 days) had resolved. At the time of the report, VACCINATION SITE WARMTH (hot to touch), VACCINATION SITE ERYTHEMA (arm  red) and VACCINATION SITE SWELLING (swollen down to her elbow) outcome was unknown and VACCINATION SITE PRURITUS (arm Itchy) was resolving.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       As reported by the consumer from the TCR follow up on 6-Jul-21, she used anti-itch cream and cold/warm compresses to treat events from her 1st vaccine and they resolved within 3-4 days. She also reported that she received the second vaccine, date and vaccine info not reported, and had no adverse events.  No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Significant TCR follow-up -outcome of the events
The pt woke up with itchy, reddened eyes and swollen lip. Denied respiratory symptoms. Treated in ER with Benadryl. Discharged.
Covid-19 #1 Moderna reaction 1/7. Next day left arm arm soreness/fatigue/neck/back pain. 1/11 began having tingling/pain and swelling lt arm and axilla, then headache described as "terrible", associated with conjunctival erythema. 1/17 headache worst, left leg numbness, which progressed to entire left side, had trouble walking. Numbness went away by 1/18 but needed to be driven to work by husband, doctors assessed her at work and vitals were ok but she was sent home early. She went to her PCP 1/26, did bW, has IGG covid. Symptoms resolved and started feeling back to herself 14days. after vaccine.  Have recommended neurology evaluation.
couple hours after the shot, headache it was worst than migraine, nausea  and fever for a day and half  , night sweats and I couldn't sleep at night for one night. In beginning of July 2021, I woke up and my left pinkie finger on the left hand. couldn't go up, trigger finger where the it was stuck there and now when I move it it feels like it popped.  Constantly tired and I wasn't like this before.  I didn't get to go see a doctor.
This spontaneous report was received from a nurse refers to unspecified number of patients of unknown age and unknown gender. On an unspecified date, the unspecified number of patients were vaccinated with of improperly stored RECOMBIVAX HB (lot# L016959 with an expiry date of 12-MAR-2018 and lot K018334 with an expiry date of 09-JUN-2016). No adverse effects were reported. Additional information has been requested.
Woke with severe arm pain and headache at 2am. Took 2 excedrine and arm pain  resolved. That morning started low grade fever, body aches, headache and very tired. Treated with tylenol every 4-6 hrs and symptoms resolved at 7pm the 03apr.
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions/allergies were not reported. On 02-OCT-2018 the patient was administered an improperly stored dose of GARDASIL 9 (lot # R004689 and expiration date 29-NOV-2020, route, strength and frequency were not reported) with properly stored sterile diluent (MERCK STERILE DILUENT) for prophylaxis. The vaccine was exposed to temperature excursion of 9 degrees Celsius to 25 degrees Celsius for 12 days. There were no previous excursions reported. The call was not because of a data logger. No adverse effect was reported. This is one of three reports from the same reporter.; Sender's Comments: US-009507513-1810USA006946: US-009507513-1810USA006947:
Symptom #1:  sixteen days after receiving second dose I developed a sinus infection.  Had not had a sinus infection in 15 years.  Dr gave me Z-Pack and prednisone steroid.  Still no relief 7 days later. Symptom #2:  also around 16 days after my second dose my tinnitus started getting louder with more shrill variations to the typical cricket chirp type of sounds I have heard for about the last 5 years.  Never any relief from these sounds!
Spouse of patient called and report patient experienced a rash on her leg and elbow of the arm where is received her 2nd dose of the Moderna Vaccine approximately at 3pm.
Pfizer pediatric (PEDS) 0.2ml dose administered as first dose to 14yo female. No reports of any adverse events in retrospective review.  Dose should have been Pfizer 12+ 0.3ml.
couldn't lay on her right side; stomach was upset but she didn't have nausea or vomiting; really tired; swelling of the size of a 50-cent piece spread out - injection site; Injection site itches; Pain in the injection site; This spontaneous case was reported by a non-health professional and describes the occurrence of VACCINATION SITE PAIN (Pain in the injection site), VACCINATION SITE SWELLING (swelling of the size of a 50-cent piece spread out - injection site), FATIGUE (really tired), HYPOKINESIA (couldn't lay on her right side) and ABDOMINAL DISCOMFORT (stomach was upset but she didn't have nausea or vomiting) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00638B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Adrenocortical carcinoma. Concomitant products included CORTISONE for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE PAIN (Pain in the injection site). On 10-Apr-2021, the patient experienced VACCINATION SITE SWELLING (swelling of the size of a 50-cent piece spread out - injection site) and VACCINATION SITE PRURITUS (Injection site itches). On 11-Apr-2021, the patient experienced FATIGUE (really tired), HYPOKINESIA (couldn't lay on her right side) and ABDOMINAL DISCOMFORT (stomach was upset but she didn't have nausea or vomiting). At the time of the report, VACCINATION SITE PAIN (Pain in the injection site), VACCINATION SITE SWELLING (swelling of the size of a 50-cent piece spread out - injection site), FATIGUE (really tired), HYPOKINESIA (couldn't lay on her right side), ABDOMINAL DISCOMFORT (stomach was upset but she didn't have nausea or vomiting) and VACCINATION SITE PRURITUS (Injection site itches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Caller stated that treatment included Tylenol, calamine lotion, and massaging the injection site. Caller states that she is taking chemotherapy drugs for her adrenocortical carcinoma.
This spontaneous report as received from a 75 years old male consumer with no drug reactions or allergies refers to himself. The patient was vaccinated with a dose of ZOSTAVAX in November, 2011. On 09-JUL-2012 the patient developed shingles on the left side of the top of his head and around his left eye following vaccination. The consumer has experienced blurred and double vision in his left eye. The consumer was seeing an eye doctor and his regular physician for consulting. BLEPHAMIDE and unspecified medication ("pills") were given for the adverse events. Magnetic resonance imaging (MRI) was performed for lab diagnostics studies (result unknown). The outcome of the patient was reported as not recovered. Additional information has been requested.
Malaise, fever, chills, body aches, bad headache,  water diarrhea, sinus pressure, and weaknesa.
This case was reported by a consumer and described the occurrence of neck pain in a elderly female patient who received SHINGRIX. Previously administered products included ZOSTAVAX. On 29th March 2018, the patient received the 1st dose of SHINGRIX. On 30th March 2018, 1 days after receiving SHINGRIX, the patient experienced neck pain, stiff neck, headache and movements reduced. On an unknown date, the patient experienced pain in arm. The patient was treated with meloxicam. On an unknown date, the outcome of the neck pain, stiff neck and movements reduced were recovering/resolving and the outcome of the pain in arm was recovered/resolved and the outcome of the headache was unknown. The reporter considered the neck pain, stiff neck, pain in arm, headache and movements reduced to be almost certainly related to SHINGRIX. Additional details were provided as follows: This case was previously reported to physician. The age at vaccination was not reported, but the patient was over age 70. The caller called response center to ask if the side effect she experienced with SHINGRIX were normal. The patient refused to give her address or even zip code. She did give an email address but stated she only wanted to received the SHINGRIX Pl no other emails. The patient refuse to gave date of birth or actual age. She states that she did not received any other vaccines on March 29th or within 4 weeks before. She refused to list names of concomitant medications. She had the SHINGRIX injection at a pharmacy. The next day after vaccination the patient had really severe neck pain, super bad stiff neck, from left to right. It was bad pain traveling from my neck into my head. The patient couldn't move neck, had a stiff neck and headache up toward ear and toward the back of jaw. The patient did not have a fever. The patient went to orthopedic doctor and was given meloxicam. It was not yet resolved. When asking her where the injection was given she said on her left arm near her shoulder (deltoid muscle). She then mentioned that her arm was painful less than a month after injection for a couple of days but that this was resolved. The patient had denied permission to contact their physician.
vomiting Started around 11pm. One initial round of vomiting, then an additional round about 15 minutes later.
nurse administered Pfizer covid vaccine 0.3 ml undiluted no symptoms reported or observation after 30 minute observation/monitoring time mom  is aware of event and reports would continue to monitor and reports that she is a "nurse" and would continue to monitor;  I attempted to contact  on 10/27/2021 but no response however, she did return call on 10/28/2021 and reports that has not had any complaints as of this time but would continue to monitor
High fever and severe chills/shaking. Terrible headache and nausea. Sensitive skin - discomfort when touched. Lower back pain. This lasted about 12 hours with headache lasting another 12 hours.
The day after immunization pt noted new pea sized left supraclavicular node on same side as flu shot the day before--verified on exam by nurse practitioner during a physical for EMT class 9/15/14. No fever.
I received my second shot on 02/05/2021.  About a month later I developed muscle pains.  These progressed over the course of the next several weeks.  On June 30, 2021, I visited my physician and was diagnosed with polymyalgia rheumatica.  I was put on a small dose of prednisone, and my symptoms subsided promptly.
ENTIRE BODY WAS ITCHY, USED BENADRYL AND THAT CALMED IT 2 DAYS